Cardiac Surgical Devices Market
Cardiac Surgical Devices Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Cardiac Surgical Devices Market Size and Growth
The global Cardiac Surgical Devices market is expected to reach $10.78 billion by 2027, with a CAGR of 4.2% during the forecast period. Advancements in technology, increasing prevalence of cardiovascular diseases, and rising geriatric population are key factors driving market growth. Key players include Medtronic, Abbott Laboratories, and Boston Scientific. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Edwards Life Science Corporation
◍ Medtronic Inc.
◍ Getinge Group
◍ Atrion Corporation
◍ Abbott Laboratories
◍ Sorin S.P.A.
◍ Terumo Medical Corporation
◍ Boston Scientific Corporation
◍ Cook Medical
◍ Angiodynamics, Inc.
◍ C. R. Bard, Inc.
◍ Trinity Biotech
◍ Abiomed, Inc.
◍ Cardinal Health
◍ CyberHeart Incorporated
◍ MedWaves Incorporated
◍ Transmedics, Inc.
The Cardiac Surgical Devices Market is highly competitive with key players such as Edwards Life Science Corporation, Medtronic Inc., Getinge Group, Abbott Laboratories, and Boston Scientific Corporation dominating the market. These companies provide innovative products and solutions to improve patient outcomes and drive market growth.
- Edwards Life Science Corporation: $3.4 billion in annual revenue - Medtronic Inc.: $30.6 billion in annual revenue - Boston Scientific Corporation: $9.8 billion in annual revenue
Request Sample Report
Market Segmentation
By Application
◍ Congenital Heart Defects
◍ Cardiac Arrhythmia
◍ Coronary Heart Disease
◍ Congestive Heart Failure
By Product
◍ Beating Heart Surgery Systems
◍ Cardiopulmonary Bypass Equipment
◍ Cardiac Ablation Devices
◍ Perfusion Disposables
Market Growth
Request Sample Report
$ X Billion USD
